Of cats and mites: withdrawal of Xolair after prolonged use.
Panasoff
J
J
D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002415:Cats; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D000069444:Omalizumab; D039981:Pyroglyphidae / Q000276:immunology*
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab